Aveanna Healthcare Stock Is Up 23%. Here's Why a Fund Still Sold $16 Million Worth
2026-05-10 08:27:01 ET
On May 8, 2026, Summit Partners disclosed in an SEC filing that it sold 2,100,000 shares of Aveanna Healthcare (NASDAQ:AVAH) , an estimated $16.23 million trade based on quarterly average pricing.
According to its SEC filing dated May 8, 2026, Summit Partners sold 2,100,000 shares of Aveanna Healthcare, with the estimated transaction value totaling $16.23 million based on the average closing price for the quarter. The fund’s quarter-end position value declined by $26.62 million, a figure reflecting both the share sale and changes in the stock’s price.
Aveanna Healthcare provides home-based healthcare services in the United States, with a focus on medically complex pediatric and adult populations. The company leverages a patient-centered care delivery platform that allows patients to remain in their homes and reduces the need for high-cost care settings. Aveanna Healthcare operates a diversified home care platform company and provides home-based healthcare services across the United States.
NASDAQ: AVAH
AVAH Trading
12.63% G/L:
$7.40 Last:
2,298,927 Volume:
$7.175 Open:
